Clinical Trial Update: Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing reparixin for efficacy and safety in pancreatic islet transplantation in type 1 diabetes has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Transplantation
• Type 1 Diabetes Mellitus

Drugs mentioned

• Reparixin (reparixin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Islet Transplantation in Diabetes Mellitus Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2019-12-18